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doi:10.1016/j.jtcvs.2008.02.051Objectives: A significant number of patients with thoracic and thoracoabdominal aor-
tic aneurysms are unsuitable for endovascular repair owing to the absence of graft seal
zones. ‘‘Hybrid’’ techniques, including open aortic debranching procedures, allow
creation of proximal and/or distal landing zones and expand the potential applications
of endovascular repair. We report our experience with aortic arch and thoracoabdomi-
nal debranching using custom fabricated Dacron branch grafts, which greatly simplify
aortic debranching by providing inflow via a single anastomosis and incorporate a side
arm for introduction of the stent graft.
Methods:Between November 14, 2005, and December 18, 2006, a total of 53 thoracic
endograft procedures were performed at our institution. Of these, 13 (25%) involved
either open aortic arch or abdominal debranching to create proximal or distal landing
zones for endovascular repair. Patients undergoing arch debranching (n5 7) had an-
eurysms involving the transverse arch with less than 2 cm of proximal landing zone
distal to the innominate artery, necessitating stent graft coverage of both the innom-
inate and left common carotid arteries. Patients undergoing complete abdominal de-
branching (n 5 6) had either thoracoabdominal aortic aneurysms (extent II, n 5 1;
extent V, n5 3) or visceral button false aneurysms after prior open thoracoabdominal
aortic aneurysm repair (n 5 2). In all cases, endovascular aneurysm exclusion was
performed at the same operation.
Results:Mean patient age was 636 11 years (range 46-83 years); all patients had sig-
nificant comorbidities, including prior open aortic surgery in 8 (62%). There were no
perioperative (30 day) deaths and no permanent neurologic deficits, either cerebrovas-
cular accident or paraparesis/paraplegia. At a mean follow-up of 7.5 6 6.0 months,
there has been no late mortality and all debranching bypass grafts remain patent with-
out need for further intervention. Computed tomographic scans demonstrate no type I
or III endoleaks, and all aneurysms are thrombosed with stable (n5 4) or decreasing
aortic dimensions (n 5 9).
Conclusions: ‘‘Hybrid’’ aortic debranching using custom fabricated Dacron branch
grafts with a single inflow source combined with endovascular aneurysm exclusion
appears to be a safe alternative to conventional open repair for thoracoabdominal
and arch aneurysms and avoids the need for cardiopulmonary bypass and aortic cross-
clamping. This technique may be ideally suited to patients with significant comorbid-
ity or prior open aortic surgery. Longer term follow-up is needed to determine the
durability of this approach.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 21
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CDAbbreviations and Acronyms
CCA 5 common carotid artery
CPB 5 cardiopulmonary bypass
CT 5 computed tomography
EEG 5 electroencephalogram
TAAA 5 thoracoabdominal aortic aneurysm
E
ndovascular repair of thoracic aortic disease is emerg-
ing as the preferred treatment strategy in a majority of
patients, inasmuch as increasing data suggest that en-
dovascular repair may be performed with lower perioperative
morbidity and mortality rates, with similar midterm survival,
as compared with standard open aortic repair.1,2However, an-
atomic requirements for the only thoracic endograft commer-
cially available in the United States (Gore TAG;W. L Gore &
Associates, Inc, Flagstaff, Ariz) and approved by the Food and
Drug Administration include 20 mm or more of suitable prox-
imal and distal neck length with proximal and distal neck di-
ameters of 23 to 37 mm. Because of these anatomic
constraints, a significant number of patients, many of whom
are not ideal candidates for open surgery, are excluded from
standard endovascular repair.3
Consequently, in an attempt to expand the pool of patients
suitable for endovascular repair, ‘‘hybrid’’ techniques, in-
cluding open aortic arch and thoracoabdominal debranching
procedures, have been described4-6 to allow creation of prox-
imal and/or distal landing zones for stent graft seal. Owing to
our satisfaction with the early results of thoracic endovascu-
lar aortic repair in our own patient population, we have
recently expanded the use of this technique to selected
patients with aortic arch and thoracoabdominal aortic aneu-
rysms (TAAA) who were believed to be suboptimal candi-
dates for conventional open repair. This has generally
included patients with advanced age, prior aortic surgery,
or multiple comorbidities. In the current report, we describe
our experience with aortic arch and thoracoabdominal de-
branching using custom fabricated Dacron branch grafts,
which greatly simplify aortic debranching by providing
inflow via a single anastomosis and incorporate a side arm
for introduction of the stent graft.
Materials and Methods
Between November 14, 2005, and December 18, 2006, a total of 53
thoracic endograft procedures were performed at our institution. Of
these, 13 (25%) involved either open aortic arch or abdominal
debranching to create proximal or distal landing zones for endovas-
cular repair (Table E1). Indications for surgery included either sac-
cular or fusiform aneurysm (n 5 11) or false aneurysm after prior
aortic surgery (n 5 2). Criteria for repair included symptoms, rapid
enlargement (.5 mm in 12 months), or absolute size. For fusiform
aneurysms, this generally included a diameter of 6 cm or more,
whereas for saccular aneurysms a protrusion of 2 cm or more beyond
the aortic wall for the saccular component was considered an indica-22 The Journal of Thoracic and Cardiovascular Surgery c Julytion for treatment in the absence of symptoms.6A Patients undergo-
ing arch debranching (n 5 7) had aneurysms involving the
transverse arch with less than 2 cm of proximal landing zone distal
to the innominate artery, necessitating stent graft coverage of both
the innominate and left common carotid arteries (CCAs) (Figure 1,
A). Arch debranching was performed without cardiopulmonary by-
pass (CPB) via a median sternotomy with extension of the incision
along the anterior border of the left sternocleidomastoid muscle. The
procedure involves creating inflow from the proximal ascending
aorta using trifurcated grafts (Vascutek USA, Ann Arbor, Mich)
originally designed for head vessel reimplantation during open total
arch replacement (Figure E1) or with a new ‘‘hybrid antegrade
graft’’ (Vascutek USA) (Figure E2) designed to debranch the in-
nominate artery and left CCAwith concomitant antegrade stent graft
insertion across the aortic arch without the need for femoral expo-
sure (Figure 2). In either case, the proximal anastomosis to the prox-
imal ascending aorta is performed first by a partial occlusion clamp
technique (Figure E1, A) after administration of 100 U/kg intrave-
nous heparin to a goal activated clotting time of 250 seconds or
more. After completion of this anastomosis, the left CCA is
dissected free above its origin from the aortic arch. Care is taken
not to manipulate the proximal portion of the artery before clamp
placement to minimize the potential for cerebral embolization. A
5-minute test occlusion of the carotid is then carried out with intra-
operative electroencephalogram (EEG) monitoring to ensure ade-
quate perfusion of the left side of the brain despite proximal left
CCA clamping. In the event of focal EEG slowing indicative of ce-
rebral ischemia, blood pressure augmentation is performed and the
test clamp repeated. No patient in this series demonstrated EEG
changes that persisted after blood pressure augmentation. Although
not required in this series, potential alternatives in the setting of EEG
changes unresponsive to blood pressure augmentation include the
use of a shunt from the ascending aortic debranching graft to the
arch vessel or the use of CPB with mild hypothermia to prolong
the tolerable period of arch vessel clamping.
After successful test occlusion, the carotid is reclamped and di-
vided. End-to-end anastomosis of the first side branch to the left
CCA is then carried out with running 5-0 monofilament suture
and the carotid reperfused after careful deairing. The proximal
stump of the left CCA is then oversewn. The same procedure is
then followed for the innominate artery. The left subclavian artery
was not debranched but simply covered in all patients in this series.
Prior work has demonstrated the safety of left subclavian coverage
in selected patients7; adequacy of contralateral vertebral flow was
confirmed preoperatively in all patients with ultrasonagraphy as
well as computed tomographic (CT) imaging. In addition, all pa-
tients having arch debranching undergo preoperative transthoracic
echocardiography and coronary angiography to rule out significant
valvular or coronary artery disease, which should be addressed
surgically at the time of the procedure.
Patients undergoing complete abdominal debranching (n 5 6)
had either TAAAs (extent II, n 5 1; extent V, n 5 3) (Figure 3)
or visceral button false aneurysms after prior open TAAA repair
(n5 2) (Figure E3). Given the low rate of spinal cord complications
with endovascular repair,1,2,5,6 the presence or absence of patent
intercostals did not factor into the decision for conventional open
versus hybrid TAAA repair. All patients underwent midline laparot-
omy to allow full access to the celiac axis, superior mesenteric2008
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CDFigure 1. A. Preoperative 3-dimensional
CT scan reconstruction of a large trans-
verse arch aneurysm. Note adequate
proximal landing zone in ascending
aorta and distal landing zone in de-
scending thoracic aorta. B. One-month
postoperative CT scan from the same
patient demonstrating arch debranch-
ing graft extending from proximal as-
cending aorta to left common carotid
and innominate arteries. Two stent
grafts have been placed, which cover
the ostia of the innominate, left common
carotid, and left subclavian arteries.artery, both renal arteries, as well as the iliacs. Cerebrospinal fluid
drains as well as lumbar epidural catheters were placed preopera-
tively in all patients having abdominal debranching for spinal cord
protection and postoperative analgesia, respectively. Mobilization
of the left colon and takedown of the splenic flexure allows exposure
of the left renal and superior mesenteric arteries at their origins from
the aorta. Splenectomy (required in n5 3) may facilitate this expo-
sure, although we do not advocate its routine performance. The ce-
liac axis is isolated at its origin from the aorta in the lesser sac above
the pancreas. The hepatic flexure of the colon is taken down and
a limited Kocher maneuver performed. This allows isolation of
the right renal artery where it emerges beneath the inferior vena
cava. After completion of vessel exposure at their origins from the
aorta, systemic heparin at a dose of 100 U/kg was administered to
a goal activated clotting time of 250 or more. Inflow was via a single
proximal anastomosis from the left iliac system (n5 5) or infrarenal
aorta (n 5 1); the latter patient (patient 2) was status-post prior ex-
tent II TAAA repair and had an 8.7-cm visceral button false aneu-
rysm (Figure E3, A). Because her aortic bifurcation and bilateral
common iliac arteries below her prior TAAA graft were aneurysmal
as well, her distal aorta and common iliacs were replaced with a bi-
furcated Dacron graft. The mesenteric debranching graft was then
anastomosed end to side to this new aortic graft (Figure E3, B).The Journal of ThoThe mesenteric and renal debranching procedures were per-
formed in all cases by either trifurcated (Figure 4, A) or 4-vessel
branch grafts (Figure 4, B) (Vascutek USA) with distal anastomoses
to the left renal artery, superior mesenteric artery, celiac axis, and
right renal artery. These specialty multibranch grafts consist of
a 14-mm main body with either 10-mm or 8-mm side branches.
The proximal end of the 14-mm main body was anastomosed end
to side with 4-0 monofilament suture to the left iliac artery or an in-
frarenal aortic graft to provide inflow for the mesenteric and renal
arteries. The distal anastomoses were generally performed in an
end-to-end manner, with the proximal vessels being divided and
oversewn at their origins from the aorta to prevent retrograde type
II endoleak (Figure 4); occasionally, the celiac axis was sewn end
to side to the terminal limb of the debranching Dacron graft (Figures
3, 4, A, and E4). A 10-mm side limb attached to the proximal end of
the mesenteric debranching graft just above the inflow anastomosis
allowed for antegrade stent graft deployment without the need for
additional groin or iliac exposure. The debranching graft was gener-
ally covered with omentum, if available, at the completion of the
procedure.
In all cases, endovascular aneurysm exclusion was performed at
the same operation with the Gore TAG device (W. L Gore & Asso-
ciates, Inc). This device consists of a self-expanding unibody graftFigure 2. A. Intraoperative marker arte-
riogram demonstrating large aortic arch
aneurysm and completed proximal as-
cending aorta to left common carotid
and innominate artery bypass. The stent
graft introducer sheath has been ad-
vanced antegradely into the ascending
aorta over a stiff guidewire via the
proximal antegrade limb of the arch
debranching graft. B. Completion arterio-
gram after stent graft deployment demon-
strating complete exclusion of the
aneurysm sac by the stent grafts with
no endoleak; arch debranching graft is
widely patent.racic and Cardiovascular Surgery c Volume 136, Number 1 23
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CDFigure 3. One-month postoperative 3-
dimensional reconstruction CT scan of
a hybrid stented extent II TAAA repair
in an 83-year-old woman. Note trifur-
cated bypass graft extending from left
common iliac artery to the mesenteric
and renal vessels (A) combined with
endovascular aneurysm exclusion via
stent grafts extending from the left sub-
clavian artery to just above the aortic
bifurcation (B).with a nitinol frame and expanded polytetrafluoroethylene fabric.
Device fixation is achieved with balloon expansion after endograft
deployment. An adequate landing zone was defined as a 20-mm
length or more of suitable aorta or pre-existing Dacron graft with di-
ameters of 23 to 37 mm, in accordance with device instructions for
use. As mentioned, antegrade stent graft deployment via a 10-mm
Dacron side arm has become our preferred technique inasmuch as
it avoids the need for additional femoral or iliac exposure. Gener-
ally, this involves introduction of an appropriately sized Gore intro-
ducer sheath (20F-24F) through the side arm, either antegradely into
the ascending aorta for arch debranching (Figures 5 and E5) or ret-
rogradely into the infrarenal aorta for visceral debranching proce-
dures. This strategy allows rapid deployment of the endograft
after great vessel or visceral revascularization and adds only a short
time to the operative procedure. We strongly prefer completing the
operation in a single setting rather than staged endograft deployment
during a delayed subsequent procedure as described by others.8 On-
line monitoring of spinal cord function with somatosensory and mo-
tor evoked potentials was used in all patients in this series according
to previously described techniques.9
Comorbidities were defined according to standard definitions.
All procedural outcomes and complications were prospectively re-
corded. Patient follow-up included clinical examination and CT im-
aging at 1 month, 6 months, and 12 months postoperatively and
annually thereafter. All data are presented in accordance with the
‘‘Reporting Standards for Endovascular Aortic Aneurysm Repair’’
of the Ad Hoc Committee for Standardized Reporting Practices in
Vascular Surgery of The Society for Vascular Surgery/American
Association for Vascular Surgery.10 The study was approved by
the Duke Institutional Review Board and informed consent was
obtained from all patients.
Results
Patient Demographics
Patient demographics are presented in Table E1. Mean pa-
tient age was 63 6 11 years (range 46-83 years); all patients
had significant comorbidities, including prior open aortic sur-
gery in 8 (62%), and were at high risk for conventional open
repair. Aneurysms were degenerative in 11 patients and anas-24 The Journal of Thoracic and Cardiovascular Surgery c Julytomotic false aneurysms after prior aortic surgery in 2. The
latter were both visceral button false aneurysms after
TAAA repair 6 months (patient 10) and 6 years (patient 2)
earlier. Of the 11 degenerative aneurysms, 1 (patient 1) distal
arch aneurysm was due to chronic type B dissection in
a patient who originally underwent emergency thoracic
endografting for relief of mesenteric malperfusion resulting
from an acute type B dissection several months earlier. In fol-
low-up, a large (7.8 cm) aneurysm of the distal arch/proximal
descending thoracic aorta developed. Additional proximal
endovascular cuff placement to the level of the left CCA
failed to obtain a proximal seal and thus an arch debranching
procedure was subsequently performed with further proximal
endovascular extension into the ascending aorta. Another
transverse arch aneurysm (patient 3) was due to chronic
residual type A dissection after prior ascending aortic
replacement 9 years earlier.
Maximum aneurysm diameter averaged 6.5 cm (range
4.0-8.7 cm). Ten (77%) of the patients were symptomatic
with pain symptoms. Thirty-one percent (4/13) of the cases
were urgent (n5 2) (aneurysm repaired during the same hos-
pital admission as it was discovered) or emergency (n 5 2)
(aneurysm repaired within 24 hours of admission); the latter
cases were performed on an emergency basis for dynamic
mesenteric and renal malperfusion owing to acute type B dis-
section into an existing 7-cm extent V TAAA (patient 6) and
for severe abdominal and back pain with impending rupture
of a 7.4-cm visceral button false aneurysm after open TAAA
repair at another institution 6 months previously (patient 10).
All patients were in hemodynamically stable condition with-
out frank rupture at the time of surgery.
Thirty-day Outcomes
Technical success, defined as aortic debranching combined
with successful endograft deployment with secure proximal
and distal fixation,10 was achieved in all cases. One patient2008
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Dacron graft replacement for repair of an acute type A dissec-
tion 9 years earlier, required institution of CPB during arch
debranching to repair a main pulmonary artery injury; in ad-
dition, CPB with the heart decompressed greatly facilitated
dissection of the ascending graft for creation of the proximal
anastomosis of the arch debranching graft. Another patient
(patient 4) underwent concomitant on-pump coronary artery
bypass grafting immediately before arch debranching for
Figure 4. Hybrid stented TAAA repair. A, A trifurcated Dacron graft
is used to bypass the left renal, superior mesenteric, and right re-
nal arteries end to end. The celiac axis is anastomosed end to side
to the distal main body portion of the graft. All aortic side branches
are sequentially ligated at their origins (to prevent type II endo-
leak) and divided just prior to anastomosis to the debranching
graft. Thoracic endografts are then deployed to exclude the
TAAA, in the process covering the origins of the mesenteric and
renal arteries. B, A 4-branch Dacron graft is used to bypass the
left renal, superior mesenteric, celiac, and right renal arteries,
all in an end-to-end fashion. As in A, all aortic side branches
are sequentially ligated at their origins to prevent type II endoleak
and divided with subsequent anastomosis to the branches of the
Dacron graft. Endovascular aneurysm exclusion is performed
during the same operation, immediately after completion of the
debranching procedure.The Journal of Tha significant left main coronary stenosis discovered on preop-
erative coronary angiography.
In-hospital/30-day mortality rate was 0%. In addition,
there were no permanent neurologic deficits, either cerebro-
vascular accident or paraparesis/paraplegia. One patient
with an extent II TAAA (patient 8) undergoing complete
mesenteric and renal debranching with endovascular stent
grafting from the left subclavian artery to the aortic bifurca-
tion had bilateral lower extremity weakness on postoperative
day 1 after ‘‘capping’’ of the cerebrospinal fluid drain; this re-
solved completely with blood pressure augmentation and ad-
ditional cerebrospinal fluid drainage to a pressure less than 10
mm Hg. No patient had new acute renal failure necessitating
hemodialysis. The obligatory period of renal ischemia inher-
ent in the hybrid TAAA procedure during renal debranching
is short, typically 8 to 12 minutes, owing to serial revascular-
ization of individual vessels with end-to-end anastomosis.
One patient with preoperative acute renal failure resulting
from dynamic renal malperfusion from an acute type B dis-
section extending into an existing extent V TAAA (patient
6) did not recover renal function postoperatively despite tech-
nically successful renal revascularization. Major complica-
tions10 were seen in 2 (15%) patients: symptomatic left
hand ischemia resulting from left subclavian artery coverage
by the stent graft and requiring left carotid-subclavian bypass
on postoperative day 2 (patient 11) and hospital-acquired
pneumonia requiring intravenous antibiotics as well as upper
gastrointestinal bleeding requiring therapeutic endoscopy
Figure 5. A, Drawing demonstrating stent graft being introduced
antegradely across the aortic arch via the proximal antegrade
limb of the debranching graft. B, After the stent graft is deployed
in position, the proximal antegrade Dacron limb is oversewn
and divided.oracic and Cardiovascular Surgery c Volume 136, Number 1 25
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stay was 9 6 7 days. Overall, 11 (85%) of 13 patients were
discharged home. Both patients (patients 6 and 10) dis-
charged to an acute rehabilitation facility required emergency
surgery and were in renal failure preoperatively.
Follow-up Outcomes
No patient was lost to follow-up. Clinical success, defined as
absence of death as a result of aneurysm-related treatment,
type I or III endoleak, graft infection or thrombosis, aneu-
rysm expansion or rupture, or conversion to open repair,10
was 100% at a mean follow-up of 7.5 6 6.0 months (range
1-18 months). One patient (patient 1) had a late (18 months)
type II endoleak with retrograde filling of the aneurysm sac
from the left subclavian artery, which was successfully
treated with coil embolization. This is the only patient to re-
quire secondary surgical or endovascular intervention to date.
Aneurysm diameter has remained stable in 4 and decreased
by 5 mm or more in 9, although aneurysm shrinkage has
been seen in all patients with a follow-up of 6 months or
more.
Discussion
Thoracic endovascular aneurysm repair is a relatively new
approach to the treatment of thoracic aortic disease. It is gain-
ing in popularity owing to low perioperative morbidity and
mortality rates as well as promising early and midterm fol-
low-up results.1,2 Application of this technology has gener-
ally been limited to disease of the intrathoracic aorta,
inasmuch as anatomic requirements for proximal and distal
seal zones preclude the repair of arch aneurysms or TAAAs.3
Although branched and fenestrated endografts are currently
being used in investigational protocols to treat aortic arch
and thoracoabdominal disease,11,12 even proponents of these
complex endovascular techniques admit that these proce-
dures are unlikely to be adopted by the average center in
the near future.12 Consequently, recent reports4-6 have de-
scribed the use of a combined endovascular and open surgical
approach to the treatment of both transverse arch aneurysms
and TAAAs with the hope that these ‘‘hybrid’’ techniques
might lower perioperative morbidity and mortality rates for
patients who are suboptimal candidates for conventional
open repair.
The current report describes our experience with aortic
arch and thoracoabdominal debranching procedures in
a group of patients deemed suboptimal candidates for con-
ventional open repair owing to significant comorbidities
such as chronic obstructive pulmonary disease, renal disease,
or prior open aortic surgery. Short-term results in these high-
risk patients were very acceptable with no perioperative
deaths, strokes, or permanent spinal cord ischemic events
and a 15% rate of major morbidity. This report differs from
prior reports,4-6 which have tended to use multiple bypass
grafts with multiple inflow sources, a technique that necessar-26 The Journal of Thoracic and Cardiovascular Surgery c Julyily complicates the debranching procedure. Although our
technique with a single inflow source theoretically places
‘‘all of one’s eggs in one basket,’’ since multiple vascular
beds are fed via a single graft, no graft occlusions were noted
in follow-up. In addition, because the single graft feeds mul-
tiple vascular beds, total graft flow should be greater, which
may further improve long-term patency. Of note, Zhou and
associates6 described a 6.4% rate of perioperative renal by-
pass thrombosis in their series in which multiple grafts
were used for abdominal debranching.
Open repair of aneurysms of the aortic arch with CPB and
deep hypothermic circulatory arrest, although now per-
formed routinely and safely in centers with expertise, still
carries a perioperative death or stroke rate approaching
15% for total arch replacement, even in expert hands.13 Like-
wise, TAAAs remain a formidable surgical challenge with
data from a national United States database suggesting a mor-
tality rate of 20% and a complication rate of over 60% for
conventional open TAAA repair in low-volume centers.14
In addition, of those patients surviving surgery, more than
20% were discharged to another institution because they
were not ready for discharge home. Although results in ex-
pert centers are clearly superior to these data with regard to
open TAAA repair,15 room for improvement certainly exists.
Consequently, the availability of a ‘‘hybrid’’ option for high-
risk patients may allow surgeons to be more selective with re-
gard to patient selection for standard open surgery, which
should lead to improved results. In addition, the ‘‘hybrid’’ op-
tion may have advantages in these high-risk patients, includ-
ing the potential to offer therapy to patients who are not
candidates for conventional open repair.
Our current indications for a hybrid debranching proce-
dure combined with endovascular aneurysm exclusion in-
clude patients with significant comorbidities who have
degenerative aneurysms of either the aortic arch or thora-
coabdominal aorta. Although 1 patient in this series had the
Marfan syndrome, we do not advocate endovascular repair
for this patient population except for instances, such as in
our patient, in which the endovascular stent graft seal zones
are completely within an existing Dacron graft. In addition,
the avoidance of redo thoracoabdominal exposure, CPB,
and aortic crossclamping would appear to make complete
abdominal debranching combined with endovascular false
aneurysm exclusion an attractive solution to the not infre-
quent problem of visceral button false aneurysm after prior
open TAAA repair. This is especially true given the signifi-
cant morbidity and mortality associated with open repair of
this complication.16 Chronic obstructive pulmonary disease
has been identified as a risk factor for adverse outcome
with both open aortic arch13 and TAAA repair.17 In the pres-
ent series, 11 (85%) of 13 patients had significant chronic ob-
structive pulmonary disease, yet the incidence of pulmonary
morbidity was quite low, with only 1 patient having a perio-
perative pneumonia requiring intravenous antibiotic therapy2008
Hughes et al Surgery for Acquired Cardiovascular Disease
A
CDand no instances of prolonged mechanical ventilation or tra-
cheostomy. Thus, these patients would also seem to be good
candidates for a hybrid approach when feasible.
In summary, ‘‘hybrid’’ aortic debranching with custom
fabricated Dacron branch grafts with a single inflow source
combinedwith endovascular aneurysmexclusion, a technique
that avoids the need for CPB and aortic crossclamping, ap-
pears to be a safe alternative to conventional open repair
for thoracoabdominal and aortic arch aneurysms. This
technique may be ideally suited to patients with significant
comorbidity or prior open aortic surgery. Longer term fol-
low-up is needed to determine the durability of this ap-
proach.18 However, given that the long-term survival of
patients undergoing repair of degenerative thoracic and thor-
acoabdominal aneurysms is limited (eg, approximately 30%
survival at 10 years after open TAAA repair,19,20 this latter
concern is unlikely to be an issue in the majority of these
patients.
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Discussion
DrD. CraigMiller (Stanford, Calif). I would like to welcome Chad
Hughes to the Western Thoracic. If you keep doing this for 15 years
in a row, like Walter Wolfe, we will make you an honorary member.
It is nice to see the work from Duke come out west.
I want to compliment you for doing it right. You have a combined
cardiothoracic and vascular surgical team in which the cardiotho-
racic surgeon is involved at the first step, the decision-making
step, should anything be done regardless of whether it is endovascu-
lar or open. That is crucial, and I think that is the paramount differ-
ence between the indications we have seen today, which none of us
would disagree with, and those we saw yesterday, in which a periph-
eral vascular surgeon is making that decision in a vacuum and per-
haps patients are not being well served. You have done it right, and
your results, albeit short term and small in number, are absolutely
spectacular given the protoplasm you were dealing with.
My only question involves the grafts. They were Vascutek
grafts, and I am still unclear whether they were custom fabricated
for you or whether you made them at the back table, which is
what we do. I would hope, since many of them are long tortuous
small-caliber small-flow grafts, that these were Gelsoft or knitted
grafts and not Gelweave or a woven graft or the Microvel Double
Velour Hemashield (Boston Scientific Corporation, Natick, Mass)-
knitted compared with the woven grafts we have all learned that with
low flow, a knitted graft probably is going to have better patency.
DrHughes.DrMiller, thank you very much for your comments.
I hope we can get papers on the program 15 years in a row and get
out here like Dr Wolfe.
I agree 100% with your first comment regarding the team ap-
proach. I think that is key. I learned that from Joe Bavaria at the Uni-
versity of Pennsylvania, where they have a very integrated program
with their vascular surgeons. We have modeled that at Duke, and all
these patients are reviewed jointly by me and the vascular surgeons.
We each bring something separate to the table, the vascular surgeons
especially with their endovascular techniques, which we are now
learning. I think we are where the vascular surgeons were maybe
5 to 7 years ago, when they were learning from the radiologists.oracic and Cardiovascular Surgery c Volume 136, Number 1 27
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lar surgeons. I believe over time more and more cardiac surgeons
will be involved in these kinds of procedures.
With regard to the grafts, they are Gelweave and maybe we
should switch toGelsoft grafts per your recommendation. In the early
patients in the series, we used the 3-vessel grafts that were originally
made for open arch surgery.We implanted both head vessels, and for
the belly Vascutek had a graft that had 4 side branches that we were
using. We now have had Vascutek design a special graft for the arch
that has the integrated limb and has only 2 distal side branches for the
innominate and the carotid. They have also now made us a custom
graft for the belly that has one branch that goes this way for the supe-
rior mesenteric artery, one this way for the renal, one for the celiac,
and then a longer one for the right renal with an antegrade limb. I
think if they can make the graft for you, it is a little bit better.
Dr Miller. It takes away the fun for the junior resident, though,
who no longer gets to put the grafts together.
We still go for the left subclavian if we are doing this, and I think
for the audience we should be doing this more. Number one, the an-
tegrade approach for stent graft deployment is much safer. We have
not done a lot, but every time we do it we kick ourselves for flogging
from the groin and having all those access problems that can lead to
real trouble. I think we should be doing this more, but if you are there
and you are going to bypass 2 vessels, why not bypass all 3? We
have been burned, as has everybody, with a cavalier approach to
covering the left subclavian artery. Even if you know the right
vertebral is the dominant vessel, it is not just the arm claudication
ischemic symptoms, but it is the posterior fossa basilar strokes.
They are unpredictable. I think almost everybody will now be
turning the corner into a more aggressive left subclavian revascular-
ization, whether it be a supraclavicular, carotid–subclavian transpo-
sition, or something else. You are there, and it is sitting right there.
Granted, it is deep, but you can get to it, and why not make a quadru-
ple prosthesis? Do all 3 arch vessels and your fourth limb for the
antegraft stent graft deployment, which takes 5 or 10 minutes.
Isn’t it amazing when you are close to it how easy it is compared
with when you are doing it from a long distance down below?
The pump standby that you mentioned is key. As recently as 2
weeks ago, one of these end-to-side proximal anastomoses dehisced28 The Journal of Thoracic and Cardiovascular Surgery c Julyoff the ascending aorta right before our eyes, and the patient needed
the pump. It is absolutely essential, and it is going to be more impor-
tant as we move to the hybrid operating rooms, which are a little
more crowded. There is better imaging, but the pump driver and
pump must be available, because you can get into trouble. It is
also perhaps easier, warm beating partial bypass, especially if the
ascending aorta to which you are sewing is thin and friable.
DrMatthew Slater (Portland, Ore).Dr Miller stole my thunder
because we have a limited experience, but we have been anastomos-
ing to the left subclavian to obviate all the issues that come up.
My actual question is technical. In the angiography suite, the im-
aging equipment at our institution is better and so sizing is a little
more straightforward. I have found some difficulty in sizing with
fluoroscopy in the operating room. Do you have any technical hints
for using single-plane fluororoscopy in the operating room that have
been useful in the arch, which is a hard place to size?
Dr Hughes. Are you talking about sizing the stent grafts?
Dr Slater.Yes, sizing the stent grafts and positioning them in the
arch with somewhat suboptimal fluoroscopy as opposed to a fluoros-
copy suite.
Dr Hughes. I think the majority of our stent graft sizing infor-
mation comes from our preoperative imaging with a true 90 flow
lumen measurement. We use the Tera Recon system, which I
can’t say enough about. Either the IVUS (Volcano Corp, Rancho
Cordova, Calif) system or the M25S can provide very accurate
arch measurements, at least in my experience. If we have any ques-
tion we will just use IVUS, with the caveat that with the IVUS sys-
tem catheter may not be exactly in the center of the aorta. It may not
be providing a true 90 flow lumen measurement with the IVUS
catheter, but if I have any questions about sizing based on my CT
scan, I will use IVUS as kind of a tie breaker to help decide stent
graft size. On those arch grafts, we put radiographic markers around
where the proximal anastomosis comes off, which are very easily
seen during fluoroscopy. Thus, we know not to go past this point
with the stent graft. We do not have fixed imaging yet either. We
have the 9-900 OEC C-arm (Bighorn Biomedical Services, Inc,
Moorcroft, Wyo), which is acceptable but not ideal. We have
been able to use that in all these cases with pretty much no problem,
even in the big patients.2008
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CDFigure E1. Off-pump arch debranching
procedure using a trifurcated Dacron
graft. A, Intraoperative photograph of
partial occlusion clamp placed on prox-
imal ascending aorta for creation of
proximal inflow anastomosis of trifur-
cated graft. B, Completed arch de-
branching procedure with first side
branch of trifurcated graft oversewn
and not used, second side branch anas-
tomosed end to end to proximal left
common carotid artery, and distal main
body anastomosed end to end to proxi-
mal innominate artery. Note radio-
graphic markers placed around
proximal anastomosis to facilitate iden-
tification of the graft origin under fluo-
roscopy.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 28.e1
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CDFigure E2. A. Custom fabricated ante-
grade hybrid graft (Vascutek USA, Ann
Arbor, Mich) designed for arch de-
branching and antegrade stent graft de-
ployment across the aortic arch without
the need for femoral exposure. The
proximal 10-mm side arm allows intro-
duction of the stent graft introducer
sheath antegradely into the ascending
aorta. The first distal side branch is
used to bypass the left common carotid
artery (L CCA), whereas the second
distal side branch is used for the innom-
inate artery. B, Intraoperative photo-
graph demonstrating completed arch
debranching. The stent graft will subse-
quently be introduced antegradely
across the aortic arch via the proximal
side arm. C, Artist's drawing of com-
pleted arch debranching with the ante-
grade graft.28.e2 The Journal of Thoracic and Cardiovascular Surgery c July 2008
Hughes et al Surgery for Acquired Cardiovascular Disease
A
CDFigure E3. A, Preoperative CT scan of
a patient with the Marfan syndrome sta-
tus-post prior extent II TAAA repair 6
years earlier, who was discovered on
follow-up imaging to have an asymp-
tomatic 8.7-cm mesenteric button false
aneurysm (arrow). B, Nine-month post-
operative CT scan. Because the aortic
bifurcation and bilateral common iliac
arteries below the prior TAAA graft
were aneurysmal as well, the distal
aorta and common iliacs were replaced
with a bifurcated Dacron graft. The
mesenteric debranching graft was
then anastomosed end to side to this
new distal aortic graft followed by en-
dovascular false aneurysm exclusion.
Note anastomoses to the superior mes-
enteric artery, right renal, and celiac
axis (patient did not have a left kidney).
The false aneurysm has been com-
pletely excluded by the stent graft
with proximal and distal seal zones
completely within Dacron grafts and
not in the Marfan aorta.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 28.e3
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CDFigure E4. Intraoperative arteriogram demonstating debranching
graft with inflow from left iliac and distal anastomoses to left re-
nal, superior mesenteric, celiac, and right renal arteries. The ce-
liac has been anastomosed end to side to the graft in this instance.28.e4 The Journal of Thoracic and Cardiovascular Surgery c July 2008
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CDFigure E5. Intraoperative photograph demonstrating completed
debranching procedure with antegrade limb clipped and over-
sewn.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 28.e5
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CDTABLE E1. Patient demographic and clinical features
Patient
No. Comorbidities Aneurysm site Etiology Clinical classification Case urgency Prior aortic surgery
1 HTN, CAD, COPD, CRI Arch Degenerative/
chronic dissection
Symptomatic Elective Thoracic
endografting
2 CRI, HTN, Marfan syndrome Visceral
button
Anastomotic Asymptomatic Urgent Bentall, open TAAA
3 HTN, COPD, PVD Arch Degenerative/
chronic dissection
Symptomatic Elective Type A dissection
repair
4 CAD, HTN, COPD, CVD, PVD Arch Degenerative Symptomatic Elective None
5 HTN, obesity Arch Degenerative Symptomatic Elective None
6 Pre-operative
ARF, CAD, COPD, PVD
TAAA Degenerative Symptomatic;
acute type B dissection
Emergency Open AAA
7 COPD, CRI, HTN, PVD TAAA Degenerative Asymptomatic Elective Open AAA
8 COPD, HTN TAAA Degenerative Symptomatic Elective None
9 CHF, COPD, CRI, DM, HTN Arch Degenerative Asymptomatic Elective None
10 COPD, ESRD, HTN Visceral
button
Anastomotic Symptomatic Emergency Open TAAA
11 CAD, COPD, DM, HTN Arch Degenerative Symptomatic Elective None
12 COPD, HTN Arch Degenerative Symptomatic Urgent AVR
13 CAD, COPD, HTN, PVD TAAA Degenerative Symptomatic Elective Open DTA
AAA, Abdominal aortic aneurysm; ARF, acute renal failure; AVR, aortic valve replacement; CAD, coronary artery disease; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; CRI, chronic renal insufficiency; CVD, cerebrovascular disease; DM, diabetes mellitus; DTA, descending thoracic
aneurysm; ESRD, end-stage renal disease; HTN, hypertension; PVD, peripheral vascular disease; TAAA, thoracoabdominal aortic aneurysm.28.e6 The Journal of Thoracic and Cardiovascular Surgery c July 2008
